Co-Authors
This is a "connection" page, showing publications co-authored by Blase Polite and Xavier Keutgen.
Connection Strength
0.652
-
Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking. Surgery. 2026 Jan; 189:109762.
Score: 0.234
-
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases. Am J Surg. 2024 03; 229:17-23.
Score: 0.203
-
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 01; 169(1):162-167.
Score: 0.161
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 11 01; 31(11).
Score: 0.054